News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
June, 2025
June 2025
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
30  
Kohei Shitara: P2 results of futibatinib for FGFR2-amplified gastric cancer
Kohei Shitara/X
Feb 1, 2025, 07:13

Kohei Shitara: P2 results of futibatinib for FGFR2-amplified gastric cancer

Kohei Shitara, Medical Oncologist at National Cancer Center Hospital East, Japan, shared an article on X he and his colleagues authored:

“Pleased to share P2 results of futibatinib for FGFR2-amplified gastric cancer: ORR 17.9%. Shows some activity but underscores need for better options. Eagerly awaiting P3 chemo + bemarituzumab data.”

Phase 2 study of futibatinib in patients with gastric or gastroesophageal junction cancer harboring FGFR2 amplifications

Authors: Taroh Satoh et al.

Kohei Shitara: P2 results of futibatinib for FGFR2-amplified gastric cancer

cancer Hidekazu Hirano Jaffer Ajani Jill Kremer Joon Oh Park Kazunori Honda Keun-Wook Lee Kohei shitara Lucia Nogova Mark Mina Mei Liu Min-Hee Ryu Nanae Hangai OncoDaily Oncology Philippe Barthélémy Sun Young Rha Taroh Satoh Toshihiko Doi
Special Coverage
Insight
Jun 26, 2025, 17:54
E. Shyam P. Reddy: Obesity Drugs Might also Tackle Migraine
Opinion
Jun 26, 2025, 17:47
MASCC 2025 Highlights: Global Crisis of Financial Toxicity in Cancer Care
Opinion
Jun 26, 2025, 17:46
MASCC 2025 Highlights BVGH’s Global Solutions to Financial Toxicity in Cancer Care
Oncolibrary
Jun 26, 2025, 17:45
MASCC 2025 Highliths: Addressing Financial Toxicity in Cancer Supportive Care
Science
Jun 26, 2025, 17:29
Myeloma Paper of the Day, June 26th, Suggested by Robert Orlowski
Oncolibrary
Jun 26, 2025, 14:50
What Is a Chemotherapy Port? Uses, Benefits and Complications
OncoDaily Pulse
Jun 26, 2025, 14:45
Yvonne Awards 2025: Honoring Global Oncology Leaders at ASCO’s Most Inspiring Night
Blog
Jun 26, 2025, 14:20
Sendurai Mani: Gratitude and Great Science at our Lab Retreat
Oncolibrary
Jun 26, 2025, 14:14
MASCC 2025 Highlights: MuReva OM Dramatically Reduces Severe Oral Mucositis in HNC
Oncolibrary
Jun 26, 2025, 14:12
MASCC 2025 Highlights: Key Toxicity Findings in ADC-Treated Cancer Patients
Blog
Jun 26, 2025, 14:05
Mieke Van Hemelrijck Joined EORTC Board and General Assembly Meetings 2025 in Brussels
Blog
Jun 26, 2025, 13:52
Tracey O’Brien Shared Rare Cancer Patient Hamish’s Story on 2025 Rare Cancers Awareness Day